Table 1.
Characteristic | Number (%) |
---|---|
Age | |
Median (range) | 58.5 (38–76) |
Sex | |
Men | 185 (61) |
Women | 117 (39) |
Isotype | |
IgG | 177 (59) |
IgA | 63 (21) |
Light chain only | 47 (15) |
Other (IgD, IgM, Nonsecretory) | 15 (5) |
Durie-Salmon stage at diagnosis | |
I | 59 (20) |
II | 127 (42) |
III | 103 (34) |
Unknown | 13 (4) |
No. of previous treatment regimens | |
1 | 186 (62) |
>1 | 115 (38) |
Interval from diagnosis to mobilization | |
≤12 months | 237 (78) |
>12 months | 65 (22) |
Prior lenalidomide | |
Yes | 64 (21) |
No | 238 (79) |